You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monoclonal Antibodies

Showing 76 - 100 of 7,894
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allergic Rhinitis, Conjunctivitis Trial in Worldwide (REGN5713, REGN5714, REGN5715)

Completed
  • Allergic Rhinitis
  • Conjunctivitis
  • Bangor, Maine
  • +36 more
Nov 5, 2021

Thrombocytopenia, Immune Thrombocytopenia, Myelodysplasia Trial in Pessac (Blood samples)

Recruiting
  • Thrombocytopenia
  • +2 more
  • Blood samples
  • Pessac, France
    CHU de Bordeaux - service de médecine interne
May 27, 2021

Immunocompromised Trial in Mexico, United States (casirivimab+imdevimab, Placebo)

Terminated
  • Immunocompromised
  • Birmingham, Alabama
  • +66 more
Jul 26, 2022

Communicable Disease Transmission, Zoonotic Disease, Rabies Human Trial in Changchun City (recombinant anti-rabies human mAb

Completed
  • Communicable Disease Transmission
  • +4 more
  • recombinant anti-rabies human monoclonal antibody injection (SYN023)
  • Rabies Vaccine
  • Changchun City, Jilin, China
    Jilin University
Sep 23, 2021

Cancer Trial in Villejuif (Tissue sampling, Blood sampling)

Unknown status
  • Cancer
  • Tissue sampling
  • Blood sampling
  • Villejuif, Val De Marne, France
    Gustave Roussy
Apr 14, 2020

HIV Trial in Boston (PGDM1400/Placebo (3mg/kg IV), PGDM1400/Placebo (10mg/kg IV), PGDM1400/Placebo (30mg/kg IV))

Completed
  • HIV Infections
  • PGDM1400/Placebo (3mg/kg IV)
  • +7 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Sep 11, 2020

Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,

Recruiting
  • Advanced Bladder Carcinoma
  • +34 more
  • Atezolizumab
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Neuroblastoma Trial in Madison, Southampton, London (Nivolumab, Ch14.18/CHO)

Recruiting
  • Neuroblastoma
  • Madison, Wisconsin
  • +2 more
Mar 28, 2022

Diffuse Astrocytoma, IDH-Wildtype, Recurrent Glioblastoma Trial in United States (biological, procedure, radiation)

Suspended
  • Diffuse Astrocytoma, IDH-Wildtype
  • Recurrent Glioblastoma
  • Atezolizumab
  • +5 more
  • Los Angeles, California
  • +73 more
Jan 31, 2023

HIV/AIDS and Infections Trial in France (Recombinant human mAb (bNAbs), Placebo)

Not yet recruiting
  • HIV/AIDS and Infections
  • Recombinant human monoclonal antibody (bNAbs)
  • Placebo
  • Bobigny, France
  • +16 more
Mar 18, 2022

Nephrotic Syndrome Steroid-Dependent Trial in Genova (Rituximab Biosimilar, Mycophenolate Mofetil)

Terminated
  • Nephrotic Syndrome Steroid-Dependent
  • Rituximab Biosimilar
  • Mycophenolate Mofetil
  • Genova, Italy
    IRCCS Istituto Giannina Gaslini
Sep 10, 2020

LEUKEMIA Trial in Houston (CAMPATH-1H, Anti-CD45, Ara-C)

Completed
  • LEUKEMIA
  • Houston, Texas
  • +1 more
Jan 15, 2020

Inactivated Trivalent Influenza Vaccine on NSCLC Patients

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Influenza Vaccine
  • PD-1/PD-L1 inhibitors
  • Inactivated trivalent influenza vaccine
  • Hong Kong, Hong Kong, China
  • +1 more
Apr 20, 2020

Biliary Tract Cancer, Candonilimab, Claudin 18.2 Trial in Shanghai (cardonilizumab, LM-302)

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Shanghai, China
    Zhongshan hospital, Fudan University
Aug 12, 2023

Migraine Trial in Glostrup (Eptinezumab, PACAP-38)

Recruiting
  • Migraine
  • Glostrup, Denmark
    Danish headache center
Dec 1, 2022

COVID-19 International Drug Pregnancy Registry

Recruiting
  • Covid19
  • Antiviral Agents
  • Monoclonal antibody
  • Los Angeles, California
    Pregistry
Jul 20, 2022

Immune Disease Trial in Lille (Monoclonal anti-cd303 antibody)

Completed
  • Immune Disease
  • Monoclonal anti-cd303 antibody
  • Lille, France
    Hôpital Claude Huriez, CHU
Aug 26, 2020

COVID-19 Trial in United Kingdom, United States (AZD7442, Placebo)

Completed
Has Results
  • COVID-19
  • Guntersville, Alabama
  • +56 more
Oct 24, 2022

Classical Hodgkin's Lymphoma Trial in China (GLS-010)

Unknown status
  • Classical Hodgkin's Lymphoma
  • Guiyang, Guizhou, China
  • +4 more
Jun 8, 2020

Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS)

Recruiting
  • Migraine
  • Head Pain
    • Valladolid, Spain
      Hospital Clínico Universitario de Valladolid
    Mar 23, 2023

    Nephrotic Syndrome Trial in Ranica (Blood sampling)

    Recruiting
    • Nephrotic Syndrome
    • Blood sampling
    • Ranica, BG, Italy
      Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
    Jan 25, 2023

    Metastatic Gastric Cancer Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), Nivolumab

    Recruiting
    • Metastatic Gastric Cancer
    • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
    • Nivolumab Injection
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Aug 23, 2023

    Crohn Disease, IBD - Irritable Bowel Disease Trial (Bone Marrow MSC Derived Extracellular Vesicle Isolate)

    Not yet recruiting
    • Crohn Disease
    • IBD - Irritable Bowel Disease
    • Bone Marrow MSC Derived Extracellular Vesicle Isolate
    • (no location specified)
    Mar 29, 2022

    Migraine Disorders, Chronic Migraine, Episodic Migraine Trial in Pavia (Monoclonal antibody targeting the CGRP pathway (ligand

    Recruiting
    • Migraine Disorders
    • +2 more
    • Monoclonal antibody targeting the CGRP pathway (ligand or receptor) (mAbs)
    • Pavia, Italy
      Headache Science & Neurorehabilitation Center
    Nov 23, 2023

    Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in Canada,

    Active, not recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • +5 more
    • Anetumab Ravtansine
    • +5 more
    • Birmingham, Alabama
    • +44 more
    Feb 2, 2023